Regencell Bioscience Holdings Limited has been handling investor rights since May 28, 2026.
4 reports, 4 independent
Updated Jun 16
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regencell Bioscience Holdings Limited has been handling investor rights since May 28, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Regencell Bioscience Holdings Limited listed on the stock exchange.1 source
Regencell Bioscience Holdings Limited is handling class action inquiries and is listed on the electronic stock exchange (Nasdaq).1 source
The company is managing investor rights, with Rosen Law Firm involved.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
New York City
most populous city in the United States
Related events
- Regencell Bioscience Holdings Limited is listed on the Nasdaq exchange and maintains its legal offices in Pennsylvania.
- Regencell Bioscience Holdings Limited began trading on the electronic stock exchange on June 1, 2026, while facing a lawsuit invoking federal securities laws.
- PROCEPT BioRobotics Corporation sought investor meetings at a conference held in New York City.
- Generate Biomedicines Inc listed its shares on the Nasdaq exchange and received research notes and ratings from Cantor Fitzgerald.